Combined Steroid and Cyclosporin as First-line Treatment in Adults With Primary Immune Thrombocytopenia
Status:
Not yet recruiting
Trial end date:
2025-07-20
Target enrollment:
Participant gender:
Summary
Randomized, open-label, multicenter study to compare the efficacy and safety of cyclosporin
plus standard steroid compared to standard steroid monotherapy for the first-line treatment
of adults with primary immune thrombocytopenia (ITP).